Skip to Content
Global News Select

Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information

By Denny Jacob


Boston Scientific and Axonics each received a request for additional information from the Federal Trade Commission regarding a previously agreed upon merger.

The medical device manufacturer in January agreed to acquire Axonics for about $3.7 billion in cash, resulting in Axonics becoming a wholly-owned subsidiary of Boston Scientific.

The additional request for information extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 until 30 days after both sides have substantially complied with the request, Boston Scientific said in a securities filing.

The merger is now expected to be completed in the second half of 2024.


Write to Denny Jacob at


(END) Dow Jones Newswires

April 04, 2024 08:00 ET (12:00 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Market Updates

Sponsor Center